BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:23 PM
 | 
Nov 02, 2009
 |  BC Extra  |  Top Story

HGSI gains on Benlysta data

Human Genome Sciences Inc. (NASDAQ:HGSI) jumped $6.59 (35%) to $25.28 on Monday after it and partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said one of two doses of Benlysta belimumab met the primary endpoint in...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >